T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Biogen
BIIB
|
$968M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$576M |
| 3 |
Canadian Natural Resources
CNQ
|
$535M |
| 4 |
CAVA Group
CAVA
|
$519M |
| 5 |
Goldman Sachs
GS
|
$518M |
Top Sells
| 1 |
PNC Financial Services
PNC
|
$757M |
| 2 |
TransUnion
TRU
|
$681M |
| 3 |
Microsoft
MSFT
|
$665M |
| 4 |
Fortinet
FTNT
|
$572M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
$467M |
Sector Composition
| 1 | Technology | 24.37% |
| 2 | Healthcare | 22.65% |
| 3 | Consumer Discretionary | 12.28% |
| 4 | Financials | 11.97% |
| 5 | Industrials | 11.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Mondelez International
MDLZ
$79.3B
| $350K | ﹤0.01% |
+4,796
| New | +$350K |
|
552
Northrop Grumman
NOC
$83.2B
| $327K | ﹤0.01% |
+716
| New | +$327K |
|
553
Elevance Health
ELV
$72.4B
| $318K | ﹤0.01% |
+715
| New | +$318K |
|
554
SBA Communications
SBAC
$21.4B
| $316K | ﹤0.01% |
+1,363
| New | +$316K |
|
555
Zoetis
ZTS
$67.6B
| $297K | ﹤0.01% |
+1,720
| New | +$297K |
|
556
Applied Materials
AMAT
$124B
| $296K | ﹤0.01% |
+2,044
| New | +$296K |
|
557
Bank of America
BAC
$371B
| $282K | ﹤0.01% |
+9,797
| New | +$282K |
|
558
McKesson
MCK
$85.9B
| $274K | ﹤0.01% |
+640
| New | +$274K |
|
559
Morgan Stanley
MS
$237B
| $243K | ﹤0.01% |
+2,840
| New | +$243K |
|
560
CSX Corp
CSX
$60.2B
| $232K | ﹤0.01% |
+6,800
| New | +$232K |
|
561
Cadence Design Systems
CDNS
$94.6B
| $216K | ﹤0.01% |
+918
| New | +$216K |
|
562
Lockheed Martin
LMT
$105B
| $203K | ﹤0.01% |
+440
| New | +$203K |
|
563
Nike
NKE
$110B
| $200K | ﹤0.01% |
+1,804
| New | +$200K |
|
564
Monte Rosa Therapeutics
GLUE
$309M
| $147K | ﹤0.01% |
21,364
-1,695,701
| -99% | -$11.7M |
|
565
Leap Therapeutics
LPTX
$12M
| $111K | ﹤0.01% |
35,400
-9,944
| -22% | -$31.2K |
|
|
ADVWW
566
Advantage Solutions Warrant
ADVWW
| $76K | ﹤0.01% |
579,413
| – | – |
|
567
Kura Oncology
KURA
$732M
| – | – |
-2,450,031
| Closed | -$30M |
|
568
Leidos
LDOS
$22.8B
| – | – |
-706,059
| Closed | -$65M |
|
569
Mister Car Wash
MCW
$1.82B
| – | – |
-374,947
| Closed | -$3.23M |
|
570
On Holding
ONON
$14.6B
| – | – |
-863,547
| Closed | -$26.8M |
|
571
Palo Alto Networks
PANW
$128B
| – | – |
-1,506,140
| Closed | -$150M |
|
572
Payoneer
PAYO
$2.44B
| – | – |
-19,297,345
| Closed | -$121M |
|
573
Avidity Biosciences
RNA
$6.12B
| – | – |
-397,970
| Closed | -$6.11M |
|
|
NATI
574
DELISTED
National Instruments Corp
NATI
| – | – |
-3,533,896
| Closed | -$185M |
|
|
XM
575
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| – | – |
-764,439
| Closed | -$13.6M |
|